NCT05223036 2026-03-18
Testing Obeticholic Acid for Familial Adenomatous Polyposis
National Cancer Institute (NCI)
Phase 2 Suspended
Clinical Trials
8 trialsNCT07071961 2026-02-17
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
M.D. Anderson Cancer Center
Phase 2 Suspended
NCT05571293 2025-07-30
NEST-1
Weill Medical College of Cornell University
Phase 2 Suspended
NCT03722680 2025-04-23
RILUZOX-01
UNICANCER
Phase 2 Suspended
NCT05375708 2025-03-28
SIRIUS
UMC Utrecht
Phase 2 Suspended
NCT04840186 2024-11-12
EXCALIBUR3
Oslo University Hospital
Phase 2 Suspended
NCT01723306 2016-06-14
Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas
Roger Williams Medical Center
Phase 2 Suspended
NCT00609310 2012-02-03
Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence
Technische Universität Dresden
Phase 2 Suspended